Abstract:Gouty arthritis (GA) is a form of arthritis caused by uric acid deposition in the joints that result in intense inflammation and pain. Accumulating evidence showed the importance of the sensory neurons signal upon immune cells by releasing neuropeptides and chemokines to regulate associated immune-inflammatory response. In this study, we investigated the significance of sensory neuron neuropeptides and chemokine signals on inflammation-induced macrophages polarization during GA.Methods: We screened the mRNA expression profile during GA in dorsal root ganglion (DRG) neurons to identify the most likely candidate that mediates the neuro-immune communication. Then, we silenced specific gene expression in the DRG by lentiviral vectors in the monosodium urate (MSU)-induced ankle GA mouse model and evaluated alterations in the inflammatory response. In vitro, primary macrophages were used to investigate the neural impact on M1/M2 subtype polarization, proinflammatory cytokine production and downstream endothelial damage. Mechanism by which macrophage inflammation is induced in the DRG was evaluated by Western blot, immunofluorescence, and immunoprecipitation.Results: We found that secreted frizzled-related protein 2 (sFRP2) was the most upregulated gene in dorsal root ganglion (DRG) neurons in response to monosodium urate (MSU) deposition. Injection of LV-sFRP2-shRNA into the L4 and L5 DRG significantly suppressed inflammatory cell infiltration and M1 polarization in the synovial membrane, attenuating hyperalgesia and ankle swelling in the GA mouse model. In vitro, DRG neurons-derived sFRP2 promoted M1 polarization and macrophage migration, thereby upregulating the production of proinflammatory cytokines and preventing endothelial apoptosis. Furthermore, DRG-derived sFRP2 activated the nuclear factor (NF)-κB pathway by destabilizing the β-catenin and p65 complex.Conclusion: We demonstrated the involvement of a sensory neuron-macrophage axis in GA pathology that was regulated by sFRP2 expression in a paracrine manner. Targeting increased sFRP2 expressions in DRG provide novel insights for future GA research in both pain alleviation and treatment of gout inflammation.

The ology of neuropathy: an integrative review of the role of neuroinflammation and TNF‐α axonal transport in neuropathic pain

The Involvement of Spinal Annexin A10/NF-κB/MMP-9 Pathway in the Development of Neuropathic Pain in Rats

From Myelin Debris to Inflammatory Responses: a Vicious Circle in Diffuse Axonal Injury.

Axotomy-Induced Up-Regulation of Tumor Necrosis Factor-Alpha in the Dorsal Root Ganglia

Degeneration and regeneration of the peripheral nervous system: From Augustus Waller's observations to neuroinflammation

Microglia and spinal cord synaptic plasticity in persistent pain.

Endoneurial injection of TNF-α produces neuropathic pain behaviors

Emerging Role of Schwann Cells in Neuropathic Pain: Receptors, Glial Mediators and Myelination.

Cytotoxic Immunity in Peripheral Nerve Injury and Pain

Neuropathic pain: role of inflammation, immune response, and ion channel activity in central injury mechanisms

Tumor Necrosis Factor-Α and Neuropathic Pain

Nerve modulation therapy in gouty arthritis: targeting increased sFRP2 expression in dorsal root ganglion regulates macrophage polarization and alleviates endothelial damage

Beyond Neurons: Evidence That Immune and Glial Cells Contribute to Pathological Pain States

Cellular and molecular mechanisms driving neuropathic pain: recent advancements and challenges

Central Nervous System Targets: Glial Cell Mechanisms in Chronic Pain

Neuroinflammation in the Pathogenesis of Neuropathic Pain Syndrome

The role of microglia in the pathobiology of neuropathic pain development: what do we know?

The Role of Microglia in Neuroinflammation of the Spinal Cord after Peripheral Nerve Injury

Gene expression changes in dorsal root ganglia following peripheral nerve injury: roles in inflammation, cell death and nociception

How inflammation dictates diabetic peripheral neuropathy: An enlightening review

Day-to-day fluctuation in excretion of human pituitary gonadotropin.